The IRA Price Reset: A Game-Changer for Pharma Pricing — What It Means for Industry and Innovation
Imagine a world where the cost of life-saving medicines is no longer dictated solely by market forces, but by a government-driven mechanism designed to r…
The IRA Price Reset: What It Actually Does to Pharma Pricing, and What Comes Next Read Post »
In the relentless race to innovate, pharmaceutical companies have long relied on a strategic playbook: the patent wall. This fortress of intellectual property shields blockbuster drugs from generic competition, ensuring market exclusivity and hefty pro…
When the Patent Wall Crumbles: Secondary Abandonment and the Death of Drug Evergreening Read Post »
In the fiercely competitive world of pharmaceuticals, innovation alone isn’t enough. The real game-changer? Strategic patent licensing—unlocking hidden value, accelerating drug development, and gaining a decisive edge in the market. Yet, many companies…
The Strategic Playbook for Identifying and Securing Drug Patent Licensing Opportunities Read Post »
In the relentless race to develop groundbreaking new medicines, pharmaceutical companies often find themselves caught in a cycle of soaring R&D costs, lengthy approval processes, and uncertain returns. But what if the key to unlocking innovative th…
No Patents, No Problem: The Untapped Power of Drug Repurposing Read Post »
Unlocking the Hidden Barriers to Generic Drug Entry: The Power of Secondary Patents
In the high-stakes world of pharmaceuticals, the race to bring affordable generics to market is often more complex—and more opaque—than it appears on the surface. While…
Beyond the API: Mapping the Secondary Patent Thicket to Forecast Generic Entry Read Post »
ð¨ Attention Specialty Pharmacy Leaders: Are You Ready to Double Your Margins When Generics Hit the Market? ð¨
In the high-stakes world of specialty pharmacy, margins are razor-thin, and every percentage point counts. But what if there was a proven…
Double Your Specialty Pharmacy Margins the Day Generics Launch Read Post »
In the high-stakes world of pharmaceuticals, blockbuster drugs are the crown jewels—massively profitable, yet perilously vulnerable. As patent cliffs loom and generic competitors circle, the question isn’t just about developing innovative medicines but…
Defend Your Blockbuster Drug. Here’s the Playbook. Read Post »
ð¨ The Truth About Drug Patents and Stock Gains: Overnight Millionaires or a Decade-Long Marathon? ð¨
In the high-stakes world of biotech and pharmaceuticals, the narrative is often painted with broad strokes: a new drug patent is a golden ticket, …
In the relentless race for pharmaceutical innovation, the landscape is often viewed through the lens of new discoveries, cutting-edge research, and blockbuster launches. But what if some of the most lucrative opportunities are lurking in the shadows—hi…
The Coming Wave of Patent Cliffs: Who’s Ready for the Next Generation of Tablet Presses?
In the high-stakes world of pharmaceuticals, innovation isn’t just about new molecules—it’s also about maintaining the manufacturing backbone that keeps these medi…
Drug Patent Cliffs Tell You Who Needs a New Tablet Press Read Post »
Get new actionable insights and updates from BiotechBlog
